Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company 13therapeutics Inc.
Description20-amino acid peptide derived from a viral regulatory protein
Molecular Target
Mechanism of ActionToll-like receptor 9 (TLR9) inhibitor; Toll-like receptor 4 (TLR4) inhibitor
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard Indication Inflammation (unspecified)
Indication DetailsTreat acute otitis media (middle ear inflammation)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today